Karuna Therapeutics
IPO News: Filed S-1: Karuna Therapeutics Files $75mm IPO
Karuna Therapeutics

Karuna Therapeutics

NASDAQ:  KRTX

Size (mm):  $75

Bookrunners:  GS | CITI | WFS | WED

Major Holders:  PureTech Health | ARCH Ventures | The Wellcome Trust | Sofinnova

Description: Karuna Therapeutics is an innovative clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical need.

Reference Link:  S-1